Searched for
NATIONAL PHARMACEUTICAL PRICING AUTHORITY
'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...- European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
- Ukraine values India's engagement in restoring Black Sea freedom of navigation: FM SybihaThe meeting, which took place on the sidelines of the 81st United Nations General Assembly, also highlighted the importance of the waterway...
- Governor writes to Karnataka CM, wants Vande Mataram truncation order reconsideredKarnataka Governor Thaawarchand Gehlot urged Chief Minister D.K. Shivakumar to revoke a September 8 order limiting Vande Mataram to two sta...
- Quote of the day by Javier MarÃas: 'We don't object to our date of birth, so why object to...' - Spanish author's powerful lesson on accepting life's uncertaintyJavier Marías, an esteemed Spanish author, delved into the complexities of existence with an unmistakable prose style. His literary contrib...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- India-New Zealand FTA kicks in from October 20: Indian exporters get duty-free access from day one as both nations target Rs 35,000 crore trade by 2030India-New Zealand FTA kicks in from October 20: The India-New Zealand Free Trade Agreement will come into force on October 20, giving India...
- National highway contractors must get government permits for foreign workers, ministry clarifiesNational highway contractors must obtain government permits for hiring foreign workers. Any change in concessionaire ownership requires pri...
- ENTOD Pharmaceuticals secures patent for its insulin eye dropCurrently at the pre-clinical stage of development, the patented insulin eye drops are being investigated as a potential novel therapeutic ...
- Government to ease BA-BE study norms for domestic generic drug approvals, cut import licence timelinesPharmaceutical companies will soon find it easier to conduct drug studies. Applicants can start eligible trials after intimating the drug r...
- Drugs Panel to weigh bringing all sterile drug products under central licensing amid contamination concernsA proposal will soon be considered to centralize licensing for all sterile drug products. This move aims to tighten regulations on medicine...
- 100% tariffs on India? US House passes bill authorising new duties on Russia oil buyersThe US House of Representatives has passed legislation authorising President Donald Trump to impose tariffs of up to 100% on India, China a...
- Hospitals seek new pricing rules as Maharashtra FDA flags high markupsThe healthcare industry seeks a differentiated framework for medical device pricing reviews. Hospitals incur significant costs beyond procu...
- Global Market: Nikkei gains as investors snap up gaming, pharma stocksJapan’s Nikkei edged higher as investors bought beaten-down gaming and pharmaceutical shares, while falling crude oil prices supported sent...
- Supreme Court upholds Himachal HC ruling on drug regulator powers, impacting CDSCO enforcementThe Supreme Court dismissed the Union government's challenge to a High Court judgment. This ruling clarified jurisdiction over drug regulat...
- Centre seeks NPPA report on high markups in hospital consumablesThe Centre has requested a report from the NPPA regarding price discrepancies. Maharashtra FDA flagged significant gaps between trade price...
- NFRA to release second Staff Series on Technology in AuditThe series is in line with NFRA's obligations to suggest measures to improve overall audit quality and promote awareness of the significanc...
- Rs 11 IV for Rs 325, Rs 6 syringe for Rs 57: Tukaram Mundhe flags 2,841% inflated hospital bills that patients don't even know, sends recommendation to CentreMaharashtra FDA Commissioner Tukaram Mundhe has cited a survey showing substantial differences between procurement prices and printed MRPs ...
- Fake Cancer Drug Racket Busted: A man was selling counterfeit medicines to 100 hospitals across Bengaluru and other statesA major fake cancer drug racket has been busted in Karnataka, with investigators alleging that a licensed pharmacist supplied counterfeit m...
- Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...
Load More
